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To assess coronary vasodilator rmeraC
.fttr Wilhotupic heart
transplantation, regional myocardial perfusion was measured
with otygen-15-labetel water and dynamic positron emission
tomography in 14 cardiac allograft recipients who
were not
experiencing rejection mad who had as angiograplde evideaee
of
spieardial coronary sclerosis 15 to 73 i00tho (man t SD 43 ±
19) after transplantation (a
J
eoup 1) . Twelve aornml men with an
average age of 31 years (group 11) served as a control
group .
Regional perfusion was~mne,mured at rest and o terUle intrmeads
administration of 0.6 mglkg body weigld ofdipyridamole.
Rest ragfoal myocardial blind flow was 6emogeseausly dis-
erlhnted throughout the loft neaeside and was dgalRtently higher
in trspiant recipients (meats 1.16 16,26 mitg per min Image 0.9
to 1 .731 clue
in
.oraud sabjrcl
;mean 0.85 ±
0.13 mllg per coin
(range 0 .57 to 0.99) ; p = 0 .001) u was rest heart rote-systafvW
blood pressure product (rate-pressure product 11,'2~,55 t 2,50 v ;.
7,073 t 1,306 ; p < 0 .001). After dittvrklznseir, ;Wfusion in He
transpiant reclpteots was hooogui emit and slightly lover 2 .79 1:
1.03vs, 3.40! 1 .09 mlrg per min ; p- NS), whereas ralrprrnssare
Hear transplantation results incomplete denervation (I) and
possibly alienationn in myocardial metabolism (2) . In addi-
tion
. immune-mediated injury to the vascular endothelium
(3) and cyclospcnin-associated hypertension (4) may influ-
ence regional myocardial blood flow and perfusion autoreg-
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product was slightly higher 112,179 :t 2,266 vs. 10,95 t 1,995t
p = NS) than the value In normal subjects .
Dipyridamolevasodilatorresponse (dipyridauiolele
nmyoca ,-
dial blood flaw) ranged from 1.23 to 4 .92 (man 230 ± 1
.131
in
group I and from 2
.65 to 5
.45 13 .97 t 0.19
)
fn Oman 11 (p =
0.001). Oale.pressare product change (dipyriifmc".etaor
rae-
premere product) was markedly allumaled In Srasnplrl reoli•
tintseuspseed nsitlr eke value in normal (1 .09 ± 6
.99 vs
.
1 .56 x 0.27 mPglper mint P < 0 .601).
Normciradon far the dllferesee in rest rato-presaare product
Inn each hdivWud subject showed that the a4jasted red low
values (group 11,19 t 0.27, grasp 11 1.39 ± 6.31 mPg per min ;
p = 1951 and the dlpyddmodrramdilatu response data (group I
2.45* 0.63, group 1124411- 1 .25; p = NS) r memo groups were
ant
significantly
Afferent. Thas. In transplant recipl uln
wit are
act aperienadag rejection . On respac iveaew
of the coronary
vasculalure to dlpyrldmsmle•n eluted vasedNMMo is uniformity
preserved ameog all regions of the left veah'kdar myocardium
.
(J Am Cads Cor/mI 19)2:19:1100-6)
illation . Previous investigations (3-9) of the coronary vascu-
latdre in the orhotupic heart transplant recipient have relied
on invasive studies of blood flow, through the epicardial
coronary arteries- These studies have suggested that in the
absence of rejection, wall motion abnormality or severe
hypertrophy, vasodilator reserve after transplantation does
not significantly differ From that in normal subjects .
However, invasive studies using Doppler catheter or
coronary sinus thermodilution techniques not only are lim-
ited methodologically (10) but also do not give inflammation
on
perfusion per unit of tissue mass or on its regional
distribution. Positron emission tomog.uphy offers an seen-
rate noninvasive method for in vivo quantification of re-
gional myocardial perfusion that could be of great potential
value in assessing the physiologic behavior of coronary
arteries after transplantation and possibly act as a means of
detecting early perfusion changes due to chronic rejection or
silent coronary artery disease .
The aim of this study was to measure regional myocardial
0135.1097rnn3.50
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bkwd flow at rest and in response 1o intravenous dipyrida-
mole with use of oxygen-15 (1 s O)-h-ler-ed water and dynamic
positron emission tomography in a group of cardiac allogrtft
recipients who R ere not experiencing rejection
Method-;
S3idy patients. Fourteen male notidiabetic heart trans-
plant recipients (group II ranging in age from 2S to 62 years
(mean 50 a 10) were selected for this study . Before trans-
plantation, all patients had end-stage heart failure due to
ischemic heart disease (nine pati- . :ntsl or idiopathic dilated
cardiomyopathy Ifive patients). low studies were carried
out 13 to 72 months (mean 43 ± I f) after transplantation . All
patients had ncrmal cardiac function !mean left ventricular
ejection frociion 69 t 7% orange 57 to 761) with no evidence
of cardiac hypertrophy as assessed by left ventricdography
and (wo-dimensional echocardiography, a normal coronary
nngiogranl and no histologic (endomyocardial biopsy) or
clinical findings of cardiac rejection. The mean duati, n of
iscbemia at operation was 158 ± 53 min (range 75 to 225) .
The mean interval between the most recent annual cardiac
evaluation (angiography, endomyocardiai biopsy and echo-
cardiographv) and tine perfusion study was 7 ± 5 weeks . All
patients were maintained on a regular immunosuppressive
regimen of eycivsporitte, whose dose was adjusted to _-lain-
tais a blood level of 150 to 250 ngIn and arathioptine
12 mgfkg body weifhl) . No patient was taking corticoste-
roids . No patient had clinical or electrocardiographic I ECGI
findings compatible with
post-transplantation
myocardial
infarction. All medication (aspirin, dipyridamole
. fnro-
semide and nifedipine) other than the immunosuppressive
agents was withheld 48 h before the perfusion .mdy in all
patients .
Twelve men (group Iii with nn average age of 31 -_ 5
years were recruited to provide a normal myocardial blood
flow data base
. None had risk factors for coronary artery
discaao, previous symptt-0r; s, clinical signs or ECG evidence
of heart disease but, because cardiac catheteriration was not
clinically indicated. none had undergone Ibis study .
Informed written convent was obtained from each pa-
tient. The study protocol was approved by the Hammer-
smith and liarefield Hospital Research Ethics Committees
and the Administration of Radioactive Substances Advisory
Committee .
Scanning procedures and tracers. The technique fur mea-
suring regional myotardi7d perfusion employed in this study
was previously validated in our laboratory (11) . Briefly, this
method involves the continuous inhalation of "O-labeled
carbon dioxide (C"OI), which is transformed into tSO-
labeled water by the lung carbonic anhidrase, and rapid
dynamic positron emission tomographic scanning
. In valida-
tion studies, simultaneous measurements of regional myo-
cordial blood flow with 15O-water and gamma labeled micro-
spheres in nine closed chest dogs over a flow range of 0.5 to
101
6.1 ml rg per min yielded agord correlation between the two
methods even at high flows (p- - 0.36 + 1 .0x ; r = 09i) it l) .
rcmngr1i
.ic imaging wa pctfarntcJ watt a muhisure
SCAT 931106-12 tomograph (CTII, Fifteen-plane image ac-
quisition in a 10 .5-cm field of view eaab vs simultaneous data
collection from the whole heart (12) . Each subject was
initially rasitioned within the scanner for a 5-min rectilinear
transmission scan to allow optimal positioning of the heart in
the center of the field of view of the camera . The mainte.
nance of this position was checked by aligning washable ink
marks made on the patient's chest with a reference laser
beam from the tomograph . A 20-min transmission scan was
then obtained by exposure of an external germanium-r3 ring
source
. This was used to correct the subsequent emission
scans for tissue attenuation of th^ 511-keV rphotenk- This
scan was followed by an
oxygen-l5-labeled
carbon monox-
ide (CI'O) blood volume scan . Each subject inhaled C ISO at
a radioactive concemration of 3 MBglml for 4 into (total
activity 300 MBgl
. A 6-min data acquisition commenced
I min after the end of C"O delivery when the C 1S O had
equilibrated in the blood pool (13)
.
The emission blood pool
scan is reliant upon in vivo binding and labeling of red blood
cells by the formation of "O-carboxyhemeglobin . In each
subject
. venous blood samples were withdrawn every 2 min
during the acquisition period and counted in a Nal well
counter cross calibrated with the scanner .
Whc., activity had decayed to background levels, patients
inhaled C°0 2
far 3
.5 min at a radioactive concentration of
6 MBghttl (total activity 5.250 MB0). in the lungs . C`02 is
rapidly transformed to
110-labeled water (1,112"O)
(14), which
is a freely diffusible tracer (15i with a short half-life of 123 s .
It has a complete first pass extraction by the myocardium
(161 that is unaffected by the tissue metabolic state over a
wide range of Row rates f17) . A dynamic scanning protocol
was employed whereby ungated acquisition was initiated
30 s before the stall of C"02 inhalation, enabling; the
measurement d' background activity
(10).
The subsequent
b.5-min acquisition period, which encompassed the gas
inhalation perial and the 3-min interval after cessation of
inhalation, was divided into 24 time frames of varying length
(range 5 to 30 s) .
Blpyridamale htfarlon . When activity from
C"O2
had
decayed to backlround levels. dipyridamoie (0 .6 mgtkg) was
infused at a constant rate over 4 min into an antecubital vein.
Data acquisition and C"0
2 inhalatioe were initiated 2 min
after completion of dipyridamote infusion. An identical
scanning protocol to that descnbed earlier was again em
played . Heart rate and blood pressure were monitored
throughout the infusion and imaging periods. A three-lead
ECG was recorded throughout the acquisition period . Sys-
tolic blood pressure was meascred by a sawadv i
d
atn calf
mercury sphygmomanometer
. The rate-pressure product
was obtained in the baseline state and after dipyridamole
infusion by multiplying peak syrtviic blood pressure by peak
heart rate . For each subject, the
rate-pressure
product ratio
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was determined as the ratio of posbdipyridamolzhest tale-
ptessure product .
Data analysis . The emission data collected by the scanner
were reconstructed arid corrected for tissue attenuation . The
created images were subsequently transferred to Sun 3160
workstations for further image processing using the Mayo
Foundation "Analyze" software package and kinetic analy-
sis {Fro-Matlab mathematical software package) .
Calculation of regional myocardial blood flow- Quantita-
tive images of blood volume were calculated by dividing the
C ISO scan data by the average well courtier measurements of
C 15O activity per milliliter of blood in the venous samples .
The resultant blood volume images were need to trace
vascular regions of interest on all those plane .; r i which the
IMAI atrium could be anatomically identified
. Only regions
showing >90% recovery coefficients, that is, those regions
where the scanner estimation of the blood 0
15
0 concentra-
tion was e_;ose
in r tat measured Ly the Nal well counter,
were saected
. This procedure was followed to avoid the
underestimation of the arterial input function due to the
spatial resolution of The positron emission Iconographic
scanner (partial volume cffectl. A mean of four left atrial
regions with as average size of 100 pixels (4 cm 2
) were
projected on the dynamic &1 S0 frames, thereby creating
left altial tiute-activity curves for
H2"0.
Forthe subsequent
modeling procedures . arterial input function was produced
by taking the average of the left atria) time-activity curves .
Images from the frames obtained after cessation of the
C 15O, inhalation (frames 22 to 25) were summed and filtered
by using a low pass smoothing filler. A blood volume
subtraction was performed by using the 0 15 0 images after
they were filtered and scared (iii . Twenty-five to 30 circular
regions of interest of 5-pixel radius (equivalent to 10-mm
radius) were positioned in the four different anatomic seg-
ments of the myocardium (anterior, lateral, infervposterior
and septum) identified on each slice of the resultant 160.
water "washout" images (Fig . I). These regions were then
projected on the dynamic 14, 11
0 frames, eercraling average
tissue time-activity curves for each myocardial segment in
the same way as their arterial cannlerparls . These kinetic
data were fitted to a single tissue compartment tracer kinetic
model with a correction for the underestimation of tissue
(ACC Vol. 19 . No . I
I- ,w 102 im-A
Fiptare I . Kevresemarive example of
rest lrarsaxial images from a patient
after heart transplantation . Top corn .
Blood volume images obtained with
oxygen-15 labeled carbon monoxide .
Bottom row . Correspasding oxy-
txn-I5 water images after blood pool
rublraelion'1he homogeneous distri-
ration ortre Ou'» t-er lwtcd in I1,,
rest stale was maintained a0erdipyr-
i,famofe infusion,
activity due to the partial volume effect and the fractional
spillover of activity from kite loft ventricle into the tissue
regions of interest . This gives rice to the analytical equation
I listed in the Appendix .
Solutions to equation I were obtained by nonlinear least
squares regression analysis of the observed kinetic data for
three variables, regional myocardial blood flow, fraction of
exchangeable tissue la)- Rod spillover blood voleme tr,.ction
(Val for each myocardial segment . These variables were
calculated from a mean of at least five consecutive tissue
regions of interest. Iran each individual subject . a mean value
of myocardial blood flow was obtained from the flow values
measured in all four myocardial segments . This value was
divided by a factor of 1
.04 (density of myoevuinm) to give
flow values with units of mIg per min .
Ana¢slapfdip3Tidamotrvams'Batorreopannedata. Dipyr-
idamole vasodilator response was defined as the ralloof flow
after The vasodilatorstimulustobaseline flow- However, any
difference inflow response observed between the twogroups
may be tfltnbuted to the disparity in rest myocardial blood
flow. Experitnental evidence (201 suggests that up to a flow
rate of 2 mlrg
p:r
min, oxygen consumption and myocardial
flow me linearly related Any discrepancy in rest flow data
between the taco groans ma) therefore be coupled to a
difference in oxygen eonsumpticn . Consequently, a fairer
comparison may be made by norms lining the rest myocardial
blood flow date . i n bolt groups to the average oxygen
demand (retlected by rate-pressure product) of the transplant
group
. This was performed with use of equation 2 (Appen-
dix) .
Regional .wycea .rddial 'uiood flow after dipyridamole was
not normalized to the change in rate-pressure product as the
relative contributions of oxygen consumption and the vaso-
dilator effect of dipyridamole to the increase in flow are as
yet uncertain .
Statistical methods. Mean ± SD (or s SE fur flow mea-
surements) values were obtained for each raaabl, L!ara
analysis was performed with use of unpaired or paired r
tests, as appropriate . Correlation of coefficients were calcu-
lated with the toast-squares linear regression analysis . Prob-
ability (p) values < 0.05 were considered statistically
signif-
icant.
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ClinicalandhemodynamicBndings(Table 1). AI!!4trans-
plant recipients and 12 normal subjects tolerated the proce-
dure without serious adverse effect. Heart rte. peak systolic
arterial pressure . rate-pressure product and myocardial
blood flow at baseline and after dipyridamole infusion were
compared an sn individual basis ai;d between the two
groups . Within each group there was a significant increase in
heart rte after dipyridamole infusion (group 1'9 _ I I vs . 87
*_ 9
IP
< 0 .0011, group C 63 *_ 10 vs. 95 t 14 Ip < 0.0011) .
but no significant change in systolic blood pressure (p > 0 .05
for both gr 'ups) . Comparison of the two groups showed that
rest heart rate and blood pressure in the transplant recipients
were 25% and 23%, resoecti<dy, higher relative to values in
the normal subjects (p < 0.16)1 for both variables). This
difference explains the increase (59%) rate-pressure product
at rest in group 1 relative to that in group 11 Ip < 0 .001)
.
After
administration
of dipyridamole . the increment in rate-
pressure product was higher fret the normal subjects than for
the transplant recipients (54% vs . 8%; p < 0 .01)
.
Myocudeal blood lbw raeaoneemerlu. Rest regional myo-
cardial blood flow was significantly higher (36%) in grown I
than in group 11)1 .16 t 0.26 vs . 0.85 t 0.13 mug per min;
p < 0.001). However, adjustmentt of baseline flow values for
rate-pressure product and recalculation of myocardial blood
flow showed no statistical difference between the twogroups
!*,bit I
.
Hemodynamic
:
:nd Blood Flow Results in 26 Men
R Age
-HR Peak ;P P.PP1 'MEN
R_
No. frrl R 0 R D R D 131 R D 0VR rMlilti' UVR'
Group I l o pIorOCJ 0 ,01
59 7U 10 170 160 11 .900 12.900 L6'8
it,*
7 .91
192 0 .7E 5.17
2 54 74
96 1411
130
11#0
2490 1 .13
I.la
5,32 2 .95 1
.18 2-Ol
3
59 75 45 125 130
9 .375 1L1K0 1 .16 !.02 2 .15 3 .01 1 .22 2.57
4 56 72 78 1'-0 120 8 .640 9.360 1 .08 LIO 3 01 37, 1 .43 2.73
5 39 75 90 130 120 9750 10.90 1 .11 1 .28 2,29 1 .82 1 .48 1 .54
6 51 82 '35
IN.
150 13 .110 11.900 1 .05 0 .99
260
2 .91 0.76 3 .41
1 141 IN 104 'II IM KIN) 1664)1 1191 1 42 	. 17 ! .54 (191 2,49
1 51
74
65 ;.`0
1414
11700
I3/all
1,16
17)
2.(0 L56 166
161
4 60 94 86
130 120
10.920 10,5
2
41 095
7
.30 1,59 1 .21 1,34 1,19
10 39 66 68 12U
1
15 7,920 7?2U 099 0.95 0 .36 Ld7 135 1,02
I I 47 80 90 130 135 :0.4011 12 .150 1 .17 0.93 1 .54 L5: 1 W 1,44
I2 29 S8 IW L0 ISO 1320 150914 1.14 1,27 5.02 3.99 4,90 4,63
IS 62 15 9u IM) 141, 10.501 I2 .Nr! 1.20 093 2.38 2 .59 1 .00 2.19
14 40 67 78 160 I5.` 107211 C,O0 1.13 1 .12 7,70 I619 1,39 1 .59
Mcaa 5o '9 87 143 139 11 .255 12,!79 1,09 1 .16 2.13 2 .50 1,19 ?.47
SO 10 II 9 Is 17 2
ton 2,266
0 .09 0 .26 1 .03 1 .13 0.27 L25
p v4ae
it 11,n
<0. W 1 0,08 1E 417 <0401
0,001 0.01
01)1811
0.11 0.001 0 .12~s.groap11 <0.001 ':000) "0 .001 <0001 0001 0.09 0 .95
r nup 111n"rmal'nhioa n
78 711 88 III 115 8 .11511 10.1211 1 .6 0.91 1.17 3.02 1.27 2.18
79 97 It0 170 Its 10440 IL610 1 .77 0.44 4.53 4.2 095 ?.7?
36 50 80 I'0 115 5 .000 9. ?W 1,53 0.95 e.10 4.43 1.78 2.35
31 61 101 90 5 .714! 0.925 1 .44 4.91 1.67 4.04 1.78 2m
33 56 9U I'_It I2U 6.725 9601 1 .47 OM _'.93
3
.51 1 .41 2 .08
6 33 58 97 410 115 6 380 Ir lss
171
0 .98 4_21
4
.42
1 71 244
11 58 98 IIS 130 6.670 I-'.740 i .91 0,92 4.53 4 .95 1 .55 292
h i0 1OR iii Ili 8.000 12 . 2 : 1 .54 069 2 .46 3 .62 0 .96 2 .55
9 36 61 118 1In 530 7.150 14.300 2 .00 095 527 545 156 t . .8
10 31 55 67 420 120 6.6011 90140 1 .22 0,53 1 .52 2,65 0.97 1 .56
tt 56 58 106 Im DO s 900 110100 1 .90 0,16 3 .67 4 .71 147 249
12 1 6b 79 110 110 7.6205o
.1 10
.090 101 2 .00 274 '
4e
4,97
Mea. '3 t 63 95 142 115 7,073 li
;
.955 1 .36 0,15 2 .97 1 el 2.45
So - l0 l4 9 12 1 .306
1
.s92 0.27 0.13 3 .09 0.39 0.31 0.64
psuluc <000J1 11.24 <O,WI <0.4T11
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(group 11 .19 = 0.27, group 111 .39
._ 0
.31 : p = 0.09). A wide
range of flow values in response to dipyridamole was ob-
served in both groups (group 1 1 .38 to 5 .02 ml) per min
[mean 2 .73 . 1 .03] ; group 11 1 .52 to 5 .27 mllg per nun Imean
3 .40 ± 1 .091
; P ° NS) .
Oipyridamnte vasodilator response . The dipyridamole
vasodilator response value was significantly lower in the
transplant recipients (group I) than in group 11(2.5 m 1 .13 vs .
3,97 *_ 0.89, p =0.0)1). However, analysisof the vasodilator
rrspon,e data taking into account the difference in rest
.at
.rressur_ product (DVR' in Table 1) showed no sign!fl-
cant difference (grasp 12.47 ± 1 .25, group 112 .45 ± 0.64 ;
p = 0 .95) between the two groups
.
Regional variability of myocardial blood flow. In both
groups myocardial blood flow was homogeneously distrib-
uted throughout the entire left ventricle . In the transplant
recipients, the c efficient of variation of flow values mea-
sured in the four myocardial segments (mean intrsubject
regional variability) was 17% both before and after dipyrid-
amole infusion . The corresponding values in the normal
group were similar: 13% and 15%, respectively . The coeffi-
cient of variation of the dipyridamole vasodilator response
value derived from the same segments was 18% for the
transplant recipients and 15% for the normal group
.
Correlation between dipyridamok vasodilmor response
and clinical variables . For the entire group of transplant
recipients, there was no significant correlation between age
.
time elapsed from transplantation . left ventricular ejection
fraction or any of the other clinical variables studied and the
adjusted or nonaljnsted dipyridamole vasodilator response
data. Depressed dipyridamole vasodilator response (adjust-
ed and nonadjusted values) could not he relates to baseline
cardiac disease, prevalence rate of rejection episodes (range
I to 4 episodes, mean 2.4 ± 0 .9) in the Iit 2
mouths
after
transplantation or to operative cold ischemic time .
Discussion
The major ohservatinris of the present strtdv are 1) rest
myocardial blood flow in the transplanted hearts was homo-
geneously, distributed and higher than that ~n normal sub-
jects
; 21 the increased rest perfusion in the transplant recip-
ients was associated with a higher rte-pressure product ;
31 aftei dipyridamolc infusion. myocardial blood low was
homogeneously disttibu cd aid not significantly different
from that in the normal group ; and 4) the higher rest
rate-pressure product and consequently higher rest flow
values account for the lower dipyridamote vasodilator re-
sponse in the transplant recipients than in the normal sub-
jects . T. horse results indicate that myocardial blood now after
human onhotopic heart transplantation is homogeneously
distributed, both before and after pharmacologic stimula-
tion, a finding consistent with recently published (23) data
measuring myocardial blood fltnv at rest and after exercise .
Regional myocardial blood flow. Myocardial perfusion
was evenly distributed throughout all regions of the left
ventricular wall as evidenced by the similarity of regional
variability of myocardial blood flow in the transplant recip-
ients to that in the normal subjects. Rest flow values in our
nomal subjects were comparable with those obtained by
two other groups (21,22) using "O-date* for o"rmitative
perfu: . :~n imaging . Regional myocardial blood flow vias
sigtific:ntly higher in the transplanted hearts than in the
native hearts . This finding is consistent with earlier re1usrted
results obtained with the thermodilution method (7) and
uNH 5 and posi .ros emission tomography (231
. It was asses
.
ciated with an increased rest
;ate-pressure product, which
has also been previous); aocumented (3,7) .
In this study wa used '10-water, which is a freely
diffusible tracer raid measures flow linearly even at high flow
rates
; it is not metabolically active and its short half-life
enables repeat studies to be performed within a short period
of time . Studies have previously shown char the ale .
pressure product and oxygen consumption are well corre-
lated (24). Because myocardial oxygen consumption and
flow arc linearly related up to perfusioa values of 2 mug per
min (20), we adjusted the measured rest myocardial blood
flow data on an individual ',asis in both gunups to the mean
of it.e i~te-pressure product data acquired in the transplant
group
. This adjustment was made to normalize the differ-
ences in baseline cardiac work between the two groups .
After the normalization was performed, the estimated rest
myocardial blood flow in normal subjects was not signifi-
cantly different from that measured
in
the transplant group.
Tus, the difference in rest flow values between the two
groups is probably due to the difference in baseline meta-
bolic demand.
Caramry, flow reserve in normal sabJects. In normal
subjects, the increment in myocardial perfusion following
dipyridamole infusion is in agreement with coronary flow
velocity data obtained with the Doppler catheter method
(25), showing a peak to rest coronary flow velocity ratio
ranging from 1 .9 to 5.4 compared with our ratio oi' post-
dipyridamole to rest flow of 2.65 to 5.45 . This change in
myocardial perfusion or blood flow velocity from baseline to
that elicited by pharmacologic vasodilation is the standard
definition user, for coronary flow reserve . This assumes that
the coronary resistive vessels are maximally dilated and the
rest tissue peif
-
nsion is homogeneous in the studied .
Coronary IImo. rev-me in the transplanted heart . Pedo-
sior, autoregulmion depends on several mechanisms, princi-
pally neural control, metabolic demand and endothelial
function (26) . After heart transplantation all of these mech-
anisms may be affected . In our study, the mean hyperemic to
cor::rol myocardial blood flow ratio in the transplant recipi-
ents was 2.5 ± 1
.13 compared with 5 a- 0 .3 (5), 4 ± I-1 (8)
and 5 . : t 0.8 (9) peak to rest coronary flow velocity r tins
measured by Doppler catheter technique and induction of
hyperemia by intracorouary administration of a maximally
vasodilating dose o papaverine . There pray, be several
explanations for this difference. 1) There is a large individual
variation in coronary flow reserve after the administration of
JACC Val .
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the standard vasodilating dose of dipyddamole compared
with that observed aver intraceronary papaverine (25):
2) the possibility that the ceronarg vasculature in some of
our patients was not maximally vasodilated is a potentially
confounding actor adding to data scatter ; and 3) the Doppler
method allows the measurement of flow velocity in real time
and thus allows the identification of the peak hyperemic
response, whereas our results reflect the average tissue
perfusion during the whole acquisition period (6 min) . This
might lead to an underestimation of peak hyperemic flow
response to dipyddamole because of the low time resolution
of our method and consequently to an underestimation of
coronary flow reserve.
The limited dipyddamole vasodilator response in the
transplanted heart may be related to I I a deer :used absolute
myocardial blood flow after dipyridamole-irduced vasodila-
lion, and 2) to an increased rest myocardial blood flow (271
.
Because post-dipyridanole tissue perfusion in the two
groups was not significantly different, the latter explanation
,cent- more plausible . The higher rest tissue perfusion in the
transplanted as compared with the native heart stems largely
from the higher cardiac work load of the transplant recipi-
ents, which enforces a higher rest flow
. If this difference in
rate-pressure product is corrected for . the dipyridamole
vaaodilatorresponse is not significantly different from that in
normal subjects . Hence, coronary flow reserve da.n in
transplant recipients should be interpreted m light of the
cardiac work load at which measurements of myocardial
blood flow wet? ebnained.
For the entire group of trapsplant recd fonts, no
correla-
tion was found between the adjusted or n unadjusted dipyr-
idamole vasodilator response data and any of the clinical
variables, including time elapsed from transplantation . This
finding emphasizes that the microvascular atheronclerosit
that gradually develops after transplantation
:s not essential
to the development of reduced coronary flow userve. Ad-
ditionally, depressed dipyridamde vasodilat^r response
could not be related in this study to the rate of rejection
episodes that occurred in the lst 2 months after
transplan-
tation.
A transient reduction of coronary vasodilator cap ic-
ity has been observed in patients undergoing acute rejection
(9) ; however, functional recovery occurred after rejection
therapy . Whether transplant recipients with reduced coro-
nary flow reserve are more prone to subsequent rejection
episodes remains to be determined .
Mdbodologie considerations. The Doppler catheter tech-
nique is currently the most widely used technique for mea-
suring coronary flow rescrvu . 11UVr . .,a, has two mhin
limitations : it is an invasive technique and it measures doss
velocity in the epicardial coronary arteries and therefore
gives no direct information on regional myocardial tissue
perfusion . 150-water and dynamic positron emission tomog-
raphy, provide a noninvasive method for accurately measur-
ing regional myocardial tissue perfusion . Because the tem-
poral
resolution of this technique is lower than that of the
Doppler technique, perfusion is expressed as an average of
myocardial blood Now measured over scanning time . Fur-
ther studies assessing micmvascular and metabolic function
in the entire left ventricle would be particularly useful in
cardiac allograft recipients and patients with small vessel
atherosclerotic heart disease .
Conclusions. Our study indicates that in the transplanted
heart regional perfusion is homogeneously increased to
match its higher metabolic needs at rest . The disparity in rest
perfusion between transplant recipients and normal subjects
before pharmacologic vasodilation stay explain the reduced
dipyddamole vasodilator response that we observed in the
transplant recipients. Normalization of basrlina flow for
differences in cardiac work load between the two groups
showe7 that the dipyridamole vasodilator response was of a
similar magnitude. Thus despite chronic denervation, the
responsiveness of the coronary vasculature in the nenrejecl
.
ing transplanted heart to dipyridamole-mediated vasodilata-
tion is preserved .
Appendix
Equation I
C,,,=a rh1F-C.vesp-(rMRFIp*Ace-V,-C, .
where C,a = osygeu-t 5labeled water(Hc ' s 0) concentration seen in
the tissue region of iTterest by the scanner (cvoasis per pixel)
;
a = fraction of exchangeable tissue (ml of tissue capable of
exchanging walerrml region of intereso; rMBF = reginiwt myocar-
dial lobed flow (mllbloodl per minlmlltissue capable of exchanging
Water]) ; C, = left atria) concentration of tracer (countsd, per pixel)
men in the vascular region of interest by the scanner ;
A
= operation
of convolution; p = tissoeaaood partition coe6lci r ; of water
(0 .90 mtlbbodymlhissua)k A = physical decoy eomMant lt.338 min'
of osygen-15M: t - time (min); V, = spillover blood velame fraction
user the left •ventricle into the tissue region of interest and myaeardiat
arterial blood vohtne
.
Equation 2
R.MBF; -R-rMBF,-(R-RPP/R-RPP),
R-rMnF ;' = rest regional myocardial blood flow for each indi-
vidual subject normalized to average rate-pressure product in group
1 ; R-rMBF, - rest regional myocardial blood flow for each individ-
ual subject as determined by positron emission tarugraphy
; R-RPP;
= mean of the rest rote-pressure product data far group 1
; R-RPP; _
rest rate-pressure product for each individual subjecl .
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